Matti Välimäki

9.7k total citations
159 papers, 6.3k citations indexed

About

Matti Välimäki is a scholar working on Endocrinology, Diabetes and Metabolism, Pathology and Forensic Medicine and Orthopedics and Sports Medicine. According to data from OpenAlex, Matti Välimäki has authored 159 papers receiving a total of 6.3k indexed citations (citations by other indexed papers that have themselves been cited), including 68 papers in Endocrinology, Diabetes and Metabolism, 36 papers in Pathology and Forensic Medicine and 34 papers in Orthopedics and Sports Medicine. Recurrent topics in Matti Välimäki's work include Bone health and osteoporosis research (30 papers), Pituitary Gland Disorders and Treatments (23 papers) and Bone health and treatments (23 papers). Matti Välimäki is often cited by papers focused on Bone health and osteoporosis research (30 papers), Pituitary Gland Disorders and Treatments (23 papers) and Bone health and treatments (23 papers). Matti Välimäki collaborates with scholars based in Finland, United States and Sweden. Matti Välimäki's co-authors include Kalevi Laitinen, Eliisa Löyttyniemi, Reino Ylikahri, Timo Sane, Jorma Salmi, Marja‐Riitta Taskinen, Matti Härkönen, Camilla Schalin‐Jäntti, Riitta Tähtelä and Ulf‐Håkan Stenman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Endocrine Reviews.

In The Last Decade

Matti Välimäki

157 papers receiving 6.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Matti Välimäki Finland 49 2.5k 1.4k 1.3k 1.3k 1.3k 159 6.3k
Robert Udelsman United States 53 3.6k 1.4× 1.1k 0.8× 1.1k 0.8× 2.2k 1.6× 511 0.4× 153 11.5k
Hunter Heath United States 38 1.1k 0.4× 525 0.4× 1.1k 0.8× 1.7k 1.3× 1.4k 1.1× 129 5.9k
Neil Gittoes United Kingdom 37 1.8k 0.7× 488 0.3× 558 0.4× 689 0.5× 1.2k 0.9× 124 4.5k
Iacopo Chiodini Italy 49 3.8k 1.5× 331 0.2× 1.0k 0.8× 877 0.7× 1.3k 1.0× 209 6.9k
J. A. M. J. L. Janssen Netherlands 47 4.3k 1.7× 836 0.6× 559 0.4× 457 0.3× 351 0.3× 156 7.4k
Robert Y.L. Zee United States 41 937 0.4× 1.1k 0.7× 729 0.5× 382 0.3× 492 0.4× 131 5.9k
Unni Syversen Norway 40 470 0.2× 1.4k 1.0× 434 0.3× 1.3k 1.0× 1.6k 1.3× 123 5.4k
Ranuccio Nuti Italy 43 715 0.3× 582 0.4× 918 0.7× 1.6k 1.3× 2.4k 1.9× 253 6.4k
Hajime Orimo Japan 42 1.1k 0.4× 302 0.2× 974 0.7× 1.2k 0.9× 2.4k 1.9× 229 6.7k
J.C. Birkenhäger Netherlands 38 1.6k 0.6× 328 0.2× 1.2k 0.9× 608 0.5× 1.2k 0.9× 129 4.4k

Countries citing papers authored by Matti Välimäki

Since Specialization
Citations

This map shows the geographic impact of Matti Välimäki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matti Välimäki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matti Välimäki more than expected).

Fields of papers citing papers by Matti Välimäki

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matti Välimäki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matti Välimäki. The network helps show where Matti Välimäki may publish in the future.

Co-authorship network of co-authors of Matti Välimäki

This figure shows the co-authorship network connecting the top 25 collaborators of Matti Välimäki. A scholar is included among the top collaborators of Matti Välimäki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matti Välimäki. Matti Välimäki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
2.
Löyttyniemi, Eliisa, Hannu Väänänen, Hanna Laine, et al.. (2013). The effectiveness of teriparatide in the clinical practice—attenuation of the bone mineral density outcome by increasing age and bisphosphonate pretreatment. Annals of Medicine. 45(3). 230–235. 10 indexed citations
3.
Sintonen, Harri, et al.. (2008). Health‐related quality of life in long‐term follow‐up of patients with cured TNM Stage I or II differentiated thyroid carcinoma. Clinical Endocrinology. 70(3). 493–497. 42 indexed citations
4.
Kauhanen, Saila, Marko Seppänen, Jari Ovaska, et al.. (2008). The clinical value of [18F]fluoro-dihydroxyphenylalanine positron emission tomography in primary diagnosis, staging, and restaging of neuroendocrine tumors. Endocrine Related Cancer. 16(1). 255–265. 62 indexed citations
5.
Taskinen, Mervi, Kristiina Kananen, Matti Välimäki, et al.. (2005). Risk factors for reduced areal bone mineral density in young adults with stem cell transplantation in childhood. Pediatric Transplantation. 10(1). 90–97. 14 indexed citations
6.
Enattah, Nabil, Tuula Pekkarinen, Matti Välimäki, Eliisa Löyttyniemi, & Irma Järvelä. (2005). Genetically defined adult-type hypolactasia and self-reported lactose intolerance as risk factors of osteoporosis in Finnish postmenopausal women. European Journal of Clinical Nutrition. 59(10). 1105–1111. 46 indexed citations
7.
Caron, P., Marie Bex, D. R. Cullen, et al.. (2004). One‐year follow‐up of patients with acromegaly treated with fixed or titrated doses of lanreotide Autogel®. Clinical Endocrinology. 60(6). 734–740. 66 indexed citations
8.
Välimäki, Ville‐Valtteri, Henrik Alfthan, Kaisa K. Ivaska, et al.. (2004). Serum Estradiol, Testosterone, and Sex Hormone-Binding Globulin as Regulators of Peak Bone Mass and Bone Turnover Rate in Young Finnish Men. The Journal of Clinical Endocrinology & Metabolism. 89(8). 3785–3789. 48 indexed citations
9.
Hosking, D., S. Adámi, Dieter Felsenberg, et al.. (2003). Once weekly alendronate produces a greater increase in bone mineral density than daily risedronate. Open Repository and Bibliography (University of Liège). 1 indexed citations
10.
Välimäki, Matti, Kalevi Laitinen, Riitta Tähtelä, E Hirvonen, & Juha Risteli. (2003). The effects of transdermal estrogen therapy on bone mass and turnover in early postmenopausal smokers: A prospective, controlled study. American Journal of Obstetrics and Gynecology. 189(5). 1213–1220. 6 indexed citations
11.
Tiitinen, Aila & Matti Välimäki. (2002). Primary Infertility in 45-Year-Old Man with Untreated 21-Hydroxylase Deficiency: Successful Outcome with Glucocorticoid Therapy. The Journal of Clinical Endocrinology & Metabolism. 87(6). 2442–2445. 27 indexed citations
12.
Saarto, Tiina, Carl Blomqvist, Matti Välimäki, P. Mäkelä, & Inkeri Elomaa. (1995). 51 Clodronate improves bone mineral density in early breast cancer patients. A randomized study. European Journal of Cancer. 31. S12–S12. 1 indexed citations
13.
Tähtelä, Riitta, Pertti Koskinen, Pirjo Nuutila, et al.. (1994). Ability of two new thyrotropin (TSH) assays to separate hyperthyroid patients from euthyroid patients with low TSH. Clinical Chemistry. 40(1). 101–105. 27 indexed citations
14.
Välimäki, Matti, M Kärkkäinen, Christel Lamberg‐Allardt, et al.. (1994). Exercise, smoking, and calcium intake during adolescence and early adulthood as determinants of peak bone mass. BMJ. 309(6949). 230–235. 226 indexed citations
15.
Välimäki, Matti, et al.. (1991). Is the treatment of metastatic carcinoid tumor with interferon not as successful as suggested?. Cancer. 67(3). 547–549. 50 indexed citations
16.
Nykänen, Pirkko, Kerttu Irjala, Matti Välimäki, Kari Saarinen, & Jorma Viikari. (1989). Knowledge Modelling and Representation to Support an Interpretation Task: Experiences from Thyroid Function Diagnostics.. 467–472. 3 indexed citations
17.
Välimäki, Matti, Risto Pelkonen, K. Huikuri, et al.. (1989). Endocrine abnormalities in patients with adrenal tumours incidentally discovered on computed tomography. European Journal of Endocrinology. 121(1). 67–72. 53 indexed citations
18.
Saarinen, Kari, Pirkko Nykänen, Kerttu Irjala, Jorma Viikari, & Matti Välimäki. (1988). Interpretation of Test Results in Clinical Chemistry: A Protosystem for Thyroid Function Diagnostics.. 13(5). 241–251. 3 indexed citations
19.
Välimäki, Matti, E Nikkilä, Marja‐Riitta Taskinen, & R Ylikahri. (1986). Rapid decrease in high density lipoprotein subfractions and postheparin plasma lipase activities after cessation of chronic alcohol intake. Atherosclerosis. 59(2). 147–153. 47 indexed citations
20.
Välimäki, Matti, Matti Härkönen, & Reino Ylikahri. (1983). SERUM FERRITIN AND IRON LEVELS IN CHRONIC MALE ALCOHOLICS BEFORE AND AFTER ETHANOL WITHDRAWAL. Alcohol and Alcoholism. 15 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026